Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Published Online: 2021-09-03
Journal: Nature MedicineLoading...
Authors: Aggeliki Rapti•Aikaterini Argyraki•Aikaterini Masgala•Andrea Angheben•Antigone Kotsaki•Antonella Cingolani•Archontoula Fragkou•Carlo Selmi•Chiara Simona Cardellino•Christina Damoulari•Dimitra-Melia Myrodia•Efthymia Giannitsioti•Eleni Florou•Eleni-Ioanna Katsigianni•Emanuele Nicastri•Evangelos J. Giamarellos-Bourboulis•Evangelos Kostis•Evdoxia Kyriazopoulou•Francesco Castelli•Francesco Saverio Serino•Garyfallia Poulakou•George N. Dalekos•George Tsoukalas•Georgios Adamis•Georgios Chrysos•Giulio Cavalli•Giuseppe Ippolito•Glykeria Tzatzagou•Haralampos Milionis•Ilias Kainis•Ilias Papanikolaou•Ioannis Bliziotis•Ioannis Kalomenidis•Jesper Eugen-Olsen•Karolina Akinosoglou•Katerina Dimakou•Katerina Koliakou•Konstantina Katrini•Konstantinos Tsiakos•Lorenzo Dagna•Maria Chini•Maria Kosmidou•Maria Mouktaroudi•Maria Tsilika•Massimo Fantoni•Matteo Bassetti•Michael Doumas•Michael Samarkos•Mihai G. Netea•Miltiades Kyprianou•Nikolaos Gatselis•Orestis Liatsis-Douvitsas•Panagiotis Koufargyris•Periklis Panagopoulos•Petros Bakakos•Simeon Metallidis•Sofia Ktena•Spyridon Savvanis•Styliani Micha•Styliani Symbardi•Vasileios Kotsis•Vassiliki Rapti•Vassiliki Tzavara•Zoi Alexiou
